| 标题 |
Abstract B043: Preliminary results from a phase I/II study evaluating the safety, tolerability, and efficacy of EP0031, a next generation selective RET inhibitor, in patients with advanced RET-altered malignancies |
| 网址 | |
| DOI |
10.1158/1535-7163.targ-23-b043
doi
|
| 其它 |
期刊:Molecular Cancer Therapeutics 作者:E. Garralda; A. Guzmán; Pilar Garrido; A. Gianoukakis; Matthew H. Taylor; et al 出版日期:2023-12-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)